Key result
Diabetes linked to ~88% higher MACCE risk in elderly patients with valvular heart disease.
Why the study?
Diabetes mellitus is a known prognostic marker in elderly cardiovascular patients, but its predictive value in elderly patients with valvular heart disease is unclear.
Does diabetes mellitus worsen clinical outcomes in elderly patients with valvular heart disease?
Observational (n=532)
No
Does diabetes mellitus worsen clinical outcomes in elderly patients with valvular heart disease?
Diabetes mellitus is an independent predictor of major adverse cardiac and cerebrovascular events, specifically ischemic stroke and heart failure rehospitalization, in elderly patients with valvular heart disease.
Answers are grounded in this paper and cite their sources.
DM may flag higher MACCE risk in elderly VHD patients for monitoring; leaves open whether intervention alters outcomes.
Background. Diabetes mellitus (DM) is a prognostic marker in elderly patients with cardiovascular diseases, but its predictive value in elderly valvular heart disease (VHD) patients is unclear. This study aimed to investigate the effect of DM on the long-term outcome of elderly VHD patients. Methods. This single-center, observational study enrolled patients aged 65 and older consecutively with confirmed VHD using echocardiography. Patients, divided into the DM group and non-DM group, were followed up for major adverse cardiac and cerebrovascular events (MACCEs), including all-cause death, ischemic stroke, and heart failure rehospitalization. Results. Our study consisted of 532 patients over a median follow-up of 52.9 months. Compared with the non-DM group (n = 377), the DM group (n = 155) had higher incidences of ischemic stroke (25.2% vs. 13.5%, P = 0.001 ), heart failure rehospitalization (37.4% vs. 20.7%, P < 0.001 ), and MACCEs (60.0% vs. 35.8%, P < 0.001 ). After adjustment of confounders by the multivariable cox regression, DM appeared as an independent predictor for MACCEs (adjusted hazard ratio, aHR: 1.88; 95% confidence interval 1.42–2.48; P < 0.001 ). In the subgroup analysis of VHD etiology and functional style, conversely, DM was a protective factor for MACCEs in the patients with rheumatic VHD compared with those without rheumatic VHD (aHR: 0.43 vs. 2.27, P = 0.004 ). Conclusions. DM was an independent predictor for ischemic stroke and heart failure rehospitalization in elderly VHD patients undergoing conservative treatment.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2021) conducted an observational in Valvular heart disease (n=532). Diabetes mellitus vs. No diabetes mellitus was evaluated on Major adverse cardiac and cerebrovascular events (MACCEs) (aHR 1.88, 95% CI 1.42-2.48, p=<0.001). Diabetes mellitus independently predicted major adverse cardiac and cerebrovascular events in elderly patients with valvular heart disease (aHR 1.88; 95% CI 1.42-2.48; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: